FDA Approves LEQSELVI for Adults with Severe Alopecia Areata

446 Views

Emedinexus 07 November 2024

The FDA has approved LEQSELVI™ (deuruxolitinib) for the treatment of adults with severe alopecia areata. LEQSELVI™ is a Janus kinase (JAK) inhibitor, a class of medications that works by targeting specific pathways involved in autoimmune responses.

To comment on this article,
create a free account.

Already registered?

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.